AMGEN TO PRESENT AT CITI'S 2026 VIRTUAL ONCOLOGY LEADERSHIP SUMMIT
Amgen (NASDAQ:AMGN) will present at Citi's 2026 Virtual Oncology Leadership Summit on Wednesday, Feb. 18, 2026 at 12:15 p.m. PT.
Rhea-AI Summary
Amgen (NASDAQ:AMGN) will present at Citi's 2026 Virtual Oncology Leadership Summit on Wednesday, Feb. 18, 2026 at 12:15 p.m. PT. Jean-Charles Soria, senior vice president of oncology within global development, will deliver the presentation.
The presentation will be webcast live and archived for at least 90 days on Amgen's investor website, with timing and links listed on the Investor Relations Events Calendar.
Positive
- None.
Negative
- None.
Details
News Market Reaction – AMGN
In the Feb 17 session, AMGN gained 1.13%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Summit time
- 12:15 p.m. PT
- Citi 2026 Virtual Oncology Leadership Summit presentation time
- Summit date
- Feb. 18, 2026
- Scheduled date of Amgen’s presentation
- Webcast archive period
- 90 days
- Minimum replay availability after the event
- Current price
- $366.20
- Price before summit news, within 5% of 52-week high
- 52-week high
- $385.12
- Upper end of AMGN’s 52-week trading range
- 52-week low
- $261.43
- Lower end of AMGN’s 52-week trading range
- 20-day avg volume
- 3,224,117
- Benchmark for comparing current trading activity
- FY 2025 revenue
- $36.8 billion
- Total revenues, up 10% year-over-year (historical event)
Historical Context
-
Reported FY 2025 revenue and EPS growth with mixed product performance.
-
Announced timing and access details for Q4 and full-year 2025 webcast.
-
Headline about lawsuit over prescription drug access involving a large pharma.
-
J.P. Morgan Healthcare Conference presentation with webcast access details.
-
Announced Dark Blue Therapeutics acquisition to expand oncology portfolio.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
oncology medical
webcast technical
investor relations financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.
About Amgen
Amgen discovers, develops, manufactures and delivers innovative medicines to fight some of the world's toughest diseases. Harnessing the best of biology and technology, Amgen reaches millions of patients with its medicines.
More than 45 years ago, Amgen helped establish the biotechnology industry at its
Amgen has been consistently recognized for innovation and workplace culture, including honors from Fast Company and Forbes. Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average®, and it is also part of the Nasdaq-100 Index®, which includes the largest and most innovative non-financial companies listed on the Nasdaq Stock Market based on market capitalization.
For more information, visit Amgen.com and follow Amgen on X, LinkedIn, Instagram, YouTube, Facebook, TikTok and Threads.
CONTACT: Amgen, Thousand Oaks
Elissa Snook, 609-251-1407 (media)
Casey Capparelli, 805-447-1746 (investors)
View original content to download multimedia:https://www.prnewswire.com/news-releases/amgen-to-present-at-citis-2026-virtual-oncology-leadership-summit-302687989.html
SOURCE Amgen
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.